Novartis Ag (NVS) Change in Taxes (2009 - 2026)

Novartis Ag has disclosed Change in Taxes across 18 years of filings, most recently posting -$398.0 million for Q2 2026.

• In Q2 2026, Change in Taxes rose 41.04% year-over-year to -$398.0 million; the TTM figure through Jun 2026 stood at -$2.8 billion (down 8.51% YoY), while the FY2025 annual figure was -$2.6 billion, down 13.46% from the prior year.
• Change in Taxes came in at -$398.0 million for Q2 2026 at Novartis Ag, up from -$787.0 million in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of -$260.0 million in Q3 2022 to a low of -$1.2 billion in Q4 2025.
• Average Change in Taxes over 5 years is -$610.2 million, with a median of -$558.0 million recorded in 2024.
• Year-over-year, Change in Taxes soared 62.17% in 2022 and plunged 227.25% in 2023.
• Over 5 years, Change in Taxes stood at -$334.0 million in 2022, then sank by 227.25% to -$1.1 billion in 2023, then rose by 4.03% to -$1.0 billion in 2024, then slipped by 15.82% to -$1.2 billion in 2025, then surged by 67.24% to -$398.0 million in 2026.
• Per Business Quant data, the three most recent Change in Taxes figures were -$398.0 million in Q2 2026, -$787.0 million in Q1 2026, and -$1.2 billion in Q4 2025.